Bruderman Asset Management’s Alnylam Pharmaceuticals ALNY Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-84	Closed	-$6K	–	633
2018 Q4	$6K	Buy	84 +10	+14%	+$714	﹤0.01%	467
2018 Q3	$6K	Hold	74	–	–	﹤0.01%	298
2018 Q2	$7K	Hold	74	–	–	﹤0.01%	314
2018 Q1	$9K	Buy	+74	New	+$9K	﹤0.01%	299